Transcatheter Mitral Regurgitation Coaptation Device and System
Summary
The USPTO published patent application US20260096884A1 for a transcatheter mitral regurgitation treatment device. The invention covers a coaptation assistance element for implantation across the mitral valve, delivery systems including anchors and catheters, and methods for transcatheter implantation. The application was filed on October 9, 2025.
What changed
The USPTO published patent application US20260096884A1 directed to a device, system, and method for transcatheter treatment of mitral valve regurgitation. The application claims a coaptation assistance element configured for implantation across the mitral valve, systems incorporating the coaptation element with anchors or delivery catheters, and methods of transcatheter implantation. The application was filed on October 9, 2025 under Application No. 19354357.
Medical device manufacturers developing transcatheter valvular treatment products should monitor this patent application to assess potential freedom-to-operate implications and competitive landscape impact. Healthcare providers performing transcatheter mitral valve procedures may wish to track the prosecution of this intellectual property for awareness of future device availability.
What to do next
- Monitor patent prosecution for scope and competitive implications
- Review freedom-to-operate considerations for transcatheter mitral valve devices
- Assess competitive landscape impact on transcatheter valvular treatment market
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION
Application US20260096884A1 Kind: A1 Apr 09, 2026
Inventors
Alexander K. Khairkhahan
Abstract
The invention relates to a device for use in the transcatheter treatment of mitral valve regurgitation, specifically a coaptation assistance element for implantation across the valve; a system including the coaptation assistance element and anchors for implantation; a system including the coaptation assistance element and delivery catheter; and a method for transcatheter implantation of a coaptation element across a heart valve.
CPC Classifications
A61F 2/2454 A61B 17/064 A61F 2/2427 A61F 2/2463 A61B 2017/0649 A61B 17/068 A61F 2/2466 A61F 2210/0014 A61F 2220/0016 A61F 2250/0098
Filing Date
2025-10-09
Application No.
19354357
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.